US8964385046 - ADR
TRINITY BIOTECH PLC-SPON ADR
NASDAQ:TRIB (3/27/2024, 8:00:01 PM)
1.98
-0.04 (-1.98%)
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow and currently employs 398 full-time employees. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. The company is a provider of raw materials to the life sciences and research industries globally. The company also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot, EZ and EZ. The company supplies this market with other products through its clinical chemistry business. The company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
TRINITY BIOTECH PLC-SPON ADR
Ida Business Park, Bray, Co Wicklow, Ireland
BRAY WICKLOW
P: 35312769800
CEO: Ronan O'Caoimh
Employees: 398
Website: https://www.trinitybiotech.com/
DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal...
DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective...
Trinity Biotech plans to change its ADS ratio, enabling compliance with Nasdaq's minimum bid price requirement and affecting ADS trading on February 21.
DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio...
DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present...
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference...
Here you can normally see the latest stock twits on TRIB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: